Pharmaceutical Technology, August 2023
Testing Innovative Analytical Waters
August 03, 2023
Cover Story
47
8
Laboratories are focusing on more automated processes while also trying to maintain an efficient, safe, and personalized experience with each analytical test.
Quality Quartets in Risk-Based Qualification: ICH Q9(R1) Considerations
August 03, 2023
Special Report
47
8
Quality Quartets may be used to achieve knowledge-driven, risk-based approaches to commissioning and qualification that are consistent with ICH Q9(R1) principles.
Overcoming Challenges to Formulation Development for Pediatric Medicines
August 03, 2023
Development
47
8
The biggest hurdle is developing palatable formulations that are efficacious and patient friendly.
An Intelligent Drug Development Paradigm
August 03, 2023
Development
47
8
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.
Charting the Future of Vaccines
August 03, 2023
Manufacturing
47
8
A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.
Progressing Finished Product Inspection Through Automation
August 02, 2023
Analytics
47
8
The industry is taking steps to automate the final product inspection process for complex therapeutics.
Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023
August 02, 2023
Outsourcing
47
8
More than a third of CMOs are struggling to keep skilled technical and production staff.
Ensuring OSD Quality and Safety
August 02, 2023
Quality/Regulations
47
8
Current good manufacturing practices for oral solid dosage forms protect the product from contamination and potential errors.
A Healthier Tomorrow?
August 02, 2023
From The Editor
47
8
Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.
Phasing Out COVID-19 Regulatory Flexibilities
August 02, 2023
Regulatory Watch
47
8
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?
Industry Challenges Medicare Price Negotiation Scheme
August 02, 2023
Regulatory Watch
47
8
Manufacturer lawsuits prompt CMS to [slightly] modify pricing plan.
New Magic from mRNA
August 02, 2023
From The Editor
47
8
mRNA may be a modality whose chief advances are yet to come.
Sharing Critical Information for the Best Outcome
August 02, 2023
Ask the Expert
47
8
The more information shared, the smoother the approval process, says Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates.
Supply Chain Securities
August 02, 2023
From the CEO
47
8
Mapping America’s Pharmaceutical Supply (MAPS) Act aims to establish a database including key information about critical drugs so supply chain weaknesses can be identified.
ROSS Multi-Agitator Low-to-Medium Viscosity Mixer
August 02, 2023
Product Spotlight
47
8
The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.
Versatile Cell Line Platform
August 02, 2023
Product Spotlight
47
8
Sphere Fluidics’ Cyto-Mine is an automated cell line platform that is designed to enable screening of up to 40 million cells over the course of several hours.
Customizable mRNA Synthesis Service
August 02, 2023
Product Spotlight
47
8
Eurofins Genomics Blue Heron IVT mRNA synthesis service is designed to provide researchers a customizable solution.
Tumoroid Culture Medium Kit
August 02, 2023
Product Spotlight
47
8
Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit was specifically developed for the expansion of patient-derived tumoroids from multiple cancer indications.